Home/AivoCode/Aman Mann, PhD
AM

Aman Mann, PhD

Co-Founder & CEO

AivoCode

AivoCode Pipeline

DrugIndicationPhase
Neuroprotection CandidateSecondary Brain Injury (e.g., post-stroke, trauma)Pre-clinical
Therapeutic Antibody ProgramAlzheimer's Disease (early intervention)Discovery/Pre-clinical
AC01 (Ophthalmic Application)Optic Neuropathies including GlaucomaResearch/Pre-clinical